Your browser doesn't support javascript.
loading
Identification of Clostridioides difficile mutants with increased daptomycin resistance.
Zbylicki, Brianne R; Murphy, Claire E; Petsche, Jennifer A; Müh, Ute; Dobrila, Horia A; Ho, Theresa D; Daum, Mikaela N; Pannullo, Anthony G; Weiss, David S; Ellermeier, Craig D.
Afiliação
  • Zbylicki BR; Department of Microbiology and Immunology, The University of Iowa, Iowa City, Iowa, USA.
  • Murphy CE; Department of Microbiology and Immunology, The University of Iowa, Iowa City, Iowa, USA.
  • Petsche JA; Interdisciplinary Graduate Program in Molecular Medicine, University of Iowa, Iowa City, Iowa, USA.
  • Müh U; Department of Microbiology and Immunology, The University of Iowa, Iowa City, Iowa, USA.
  • Dobrila HA; Department of Microbiology and Immunology, The University of Iowa, Iowa City, Iowa, USA.
  • Ho TD; Department of Microbiology and Immunology, The University of Iowa, Iowa City, Iowa, USA.
  • Daum MN; Department of Microbiology and Immunology, The University of Iowa, Iowa City, Iowa, USA.
  • Pannullo AG; Department of Microbiology and Immunology, The University of Iowa, Iowa City, Iowa, USA.
  • Weiss DS; Department of Microbiology and Immunology, The University of Iowa, Iowa City, Iowa, USA.
  • Ellermeier CD; Department of Microbiology and Immunology, The University of Iowa, Iowa City, Iowa, USA.
J Bacteriol ; 206(3): e0036823, 2024 03 21.
Article em En | MEDLINE | ID: mdl-38376203
ABSTRACT
Daptomycin is a cyclic lipopeptide antibiotic used to treat infections caused by some Gram-positive bacteria. Daptomycin disrupts synthesis of the peptidoglycan (PG) cell wall by inserting into the cytoplasmic membrane and binding multiple forms of the undecaprenyl carrier lipid required for PG synthesis. Membrane insertion requires phosphatidylglycerol, so studies of daptomycin can provide insight into assembly and maintenance of the cytoplasmic membrane. Here, we studied the effects of daptomycin on Clostridioides difficile, the leading cause of healthcare-associated diarrhea. We observed that growth of C. difficile strain R20291 in the presence of sub-MIC levels of daptomycin resulted in a chaining phenotype, minicell formation, and lysis-phenotypes broadly consistent with perturbation of membranes and PG synthesis. We also selected for and characterized eight mutants with elevated daptomycin resistance. The mutations in these mutants were mapped to four genes cdsA (cdr20291_2041), ftsH2 (cdr20291_3396), esrR (cdr20291_1187), and draS (cdr20291_2456). Of these four genes, only draS has been characterized previously. Follow-up studies indicate these mutations confer daptomycin resistance by two general mechanisms reducing the amount of phosphatidylglycerol in the cytoplasmic membrane (cdsA) or altering the regulation of membrane processes (ftsH2, esrR, and draS). Thus, the mutants described here provide insights into phospholipid synthesis and identify signal transduction systems involved in cell envelope biogenesis and stress response in C. difficile. IMPORTANCE C. difficile is the leading cause of healthcare-associated diarrhea and is a threat to public health due to the risk of recurrent infections. Understanding biosynthesis of the atypical cell envelope of C. difficile may provide insight into novel drug targets to selectively inhibit C. difficile. Here, we identified mutations that increased daptomycin resistance and allowed us to better understand phospholipid synthesis, cell envelope biogenesis, and stress response in C. difficile.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 2_ODS3 / 3_ND Base de dados: MEDLINE Assunto principal: Clostridioides difficile / Daptomicina Limite: Humans Idioma: En Revista: J Bacteriol Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 2_ODS3 / 3_ND Base de dados: MEDLINE Assunto principal: Clostridioides difficile / Daptomicina Limite: Humans Idioma: En Revista: J Bacteriol Ano de publicação: 2024 Tipo de documento: Article